BBC icon

Virtus LifeSci Biotech Clinical Trials ETF
BBC

Overview Fund Trends Analyst Outlook Journalist POV

15 hedge funds and large institutions have $10.8M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $
Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.12M
2
+$934K
3
+$291K
4
LPL Financial
LPL Financial
California
+$209K
5
Morgan Stanley
Morgan Stanley
New York
+$164K

Top Sellers

1
-$1.38M
2
-$742K
3
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$4.36M
2
$2.93M
3
$1.12M
4
$857K
5
$556K
6
$389K
7
$291K
8
$253K
9
$29K
10
$26K
11
$7K
12
$7K
13
$3.22K
14
$2K
15
$1K
16
–
17
–
18
–